Clin2
NCT06773364Possibly a fitRecruiting

Early levetiracetam and head position for stroke

Suspected Stroke

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests if starting a seizure medication called levetiracetam early in the ambulance, along with a specific head position, can help people having a stroke. It is for adults who show clear stroke signs within the last 2 hours and do not have other major health problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
2,423 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have signs of a stroke (like face drooping, arm weakness, or speech trouble) that started less than 2 hours ago, and you must have a weak arm.
  • You must be awake and able to respond (not in a coma).
  • You cannot have a history of epilepsy or had a seizure when the stroke started.
  • You cannot have a serious illness like advanced cancer, severe heart failure, or need help with daily activities before the stroke.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07336992Not yet recruiting· Phase 3
Seizure prevention medicine for brain bleed recovery

This study tests whether a medicine called levetiracetam can help people recover better after a brain bleed. Half of the participants will receive the medicine, and half will receive a placebo. The goal is to see if this medicine can help improve recovery.

Bron
NCT06851078Not yet recruiting· Phase 3
Early seizure medication for brain problems in septic shock

This trial tests if giving an anti-seizure drug called levetiracetam early can help prevent or treat confusion and brain problems in people with septic shock. Septic shock is a life-threatening condition where an infection damages organs, sometimes affecting the brain.

NCT06866691Recruiting· Phase 4
Seizure prevention after traumatic brain injury

This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.

Winston-Salem, North Carolina
NCT07507097Not yet recruiting
Head position study for severe stroke recovery

This study tests whether a specific head position after stroke treatment can improve recovery. It may help people who have had a severe stroke and received clot-busting or clot-removal therapy.

Chengdu, Sichuan
NCT05610085Recruiting· Phase 2
Levetiracetam for newborn seizures: dose-finding study

This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.

San Diego, California
NCT05897658Not yet recruiting· Phase 3
Levetiracetam to prevent seizures after brain tumor surgery

This trial tests whether giving levetiracetam (a seizure-preventing medicine) before and after surgery to remove a brain tumor can reduce the chance of having seizures. It may help patients who have never had a seizure before.

Hear when a new Suspected Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.